Pediatrix Medical Group, Inc. (MD) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
8.85
↓-43% vs avg
5yr avg: 15.66
30Y Low2.8·High48.7
P/FCF
↓
7.73
↓-53% vs avg
5yr avg: 16.49
30Y Low5.9·High106.6
P/B Ratio
↓
2.32
↑+37% vs avg
5yr avg: 1.69
30Y Low0.5·High7.9
ROE
↑
20.3%
↓+315% vs avg
5yr avg: 4.9%
30Y Low-71%·High20%
Debt/EBITDA
↓
2.61
↓-61% vs avg
5yr avg: 6.68
30Y Low0.0·High16.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MD Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Pediatrix Medical Group, Inc. trades at 12.1x earnings, 24% below its 5-year average of 15.9x, sitting at the 15th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 45%. On a free-cash-flow basis, the stock trades at 7.7x P/FCF, 53% below the 5-year average of 16.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.0B | $1.8B | $1.1B | $764M | $1.3B | $2.4B | $2.1B | $2.3B | $3.0B | $5.0B | $6.2B |
| Enterprise Value | $2.2B | $2.1B | $1.5B | $1.4B | $2.0B | $3.0B | $2.8B | $4.0B | $5.0B | $6.8B | $7.9B |
| P/E Ratio → | 12.12 | 11.03 | — | — | 18.81 | 17.90 | — | — | 11.26 | 15.63 | 19.21 |
| P/S Ratio | 1.02 | 0.95 | 0.54 | 0.38 | 0.63 | 1.23 | 1.21 | 1.32 | 0.83 | 1.45 | 1.96 |
| P/B Ratio | 2.32 | 2.11 | 1.43 | 0.90 | 1.40 | 2.62 | 2.81 | 1.56 | 0.98 | 1.63 | 2.26 |
| P/FCF | 7.73 | 7.22 | 5.92 | 7.35 | 9.11 | 52.86 | 11.95 | 6.92 | 12.54 | 10.84 | 15.44 |
| P/OCF | 7.21 | 6.73 | 5.29 | 5.57 | 7.49 | 30.64 | 10.27 | 6.55 | 10.43 | 9.79 | 14.08 |
P/E links to full P/E history page with 30-year chart
MD EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Pediatrix Medical Group, Inc.'s enterprise value stands at 8.9x EBITDA, 43% below its 5-year average of 15.7x. The Healthcare sector median is 14.2x, placing the stock at a 38% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.10 | 0.76 | 0.70 | 0.99 | 1.59 | 1.60 | 2.26 | 1.36 | 1.97 | 2.48 |
| EV / EBITDA | 8.85 | 8.34 | — | 32.03 | 9.40 | 12.89 | 21.97 | 20.37 | 9.37 | 11.67 | 11.95 |
| EV / EBIT | 9.69 | 8.36 | — | — | 16.17 | 14.86 | 23.64 | 22.66 | 11.18 | 14.78 | 13.81 |
| EV / FCF | — | 8.35 | 8.27 | 13.39 | 14.26 | 68.11 | 15.82 | 11.90 | 20.58 | 14.72 | 19.52 |
MD Profitability
Margins and return-on-capital ratios measuring operating efficiency
Pediatrix Medical Group, Inc. earns an operating margin of 12.1%. Operating margins have expanded from 0.4% to 12.1% over the past 3 years, signaling improving operational efficiency. ROE of 20.3% indicates solid capital efficiency. ROIC of 14.8% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.7% | 24.7% | 22.6% | 21.1% | 23.7% | 26.9% | 25.9% | 28.3% | 27.1% | 28.9% | 32.5% |
| Operating Margin | 12.1% | 12.1% | -3.4% | 0.4% | 8.8% | 10.6% | 5.7% | 9.7% | 12.2% | 13.9% | 18.0% |
| Net Profit Margin | 8.6% | 8.6% | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% | -84.2% | 7.4% | 9.3% | 10.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 20.3% | 20.3% | -12.3% | -6.9% | 7.4% | 15.9% | -70.9% | -65.3% | 8.7% | 11.0% | 12.5% |
| ROA | 7.5% | 7.5% | -4.5% | -2.6% | 2.6% | 4.3% | -21.3% | -29.7% | 4.6% | 5.7% | 6.6% |
| ROIC | 14.8% | 14.8% | -3.9% | 0.4% | 8.2% | 10.1% | 3.2% | 3.1% | 6.8% | 7.8% | 10.6% |
| ROCE | 13.2% | 13.2% | -3.9% | 0.4% | 8.2% | 7.8% | 3.0% | 3.8% | 8.2% | 9.3% | 12.6% |
MD Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Pediatrix Medical Group, Inc. carries a Debt/EBITDA ratio of 2.6x, which is moderately leveraged (19% below the sector average of 3.2x). Net debt stands at $285M ($660M total debt minus $375M cash). Interest coverage of 7.0x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.76 | 0.87 | 0.83 | 0.80 | 1.19 | 2.41 | 1.20 | 0.64 | 0.60 | 0.62 |
| Debt / EBITDA | 2.61 | 2.61 | — | 16.13 | 3.44 | 4.53 | 14.26 | 9.07 | 3.73 | 3.18 | 2.58 |
| Net Debt / Equity | — | 0.33 | 0.57 | 0.74 | 0.79 | 0.76 | 0.91 | 1.12 | 0.63 | 0.58 | 0.60 |
| Net Debt / EBITDA | 1.13 | 1.13 | — | 14.45 | 3.39 | 2.89 | 5.38 | 8.52 | 3.66 | 3.08 | 2.50 |
| Debt / FCF | — | 1.13 | 2.34 | 6.04 | 5.15 | 15.25 | 3.87 | 4.98 | 8.04 | 3.88 | 4.08 |
| Interest Coverage | 7.02 | 7.02 | -1.49 | -0.15 | 3.05 | 2.97 | 1.06 | 1.49 | 4.78 | 6.17 | 9.06 |
MD Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.66x means Pediatrix Medical Group, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.24x to 1.66x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | 1.66 | 1.47 | 1.24 | 1.00 | 1.97 | 3.49 | 1.35 | 1.40 | 1.43 | 1.44 |
| Quick Ratio | 1.66 | 1.66 | 1.47 | 1.24 | 1.00 | 1.97 | 3.49 | 1.35 | 1.40 | 1.43 | 1.44 |
| Cash Ratio | 1.09 | 1.09 | 0.80 | 0.46 | 0.24 | 1.14 | 2.77 | 0.34 | 0.13 | 0.16 | 0.16 |
| Asset Turnover | — | 0.85 | 0.94 | 0.90 | 0.84 | 0.70 | 0.52 | 0.43 | 0.61 | 0.59 | 0.60 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 46.21 | 49.43 | 51.22 | 54.93 | 60.35 | 50.93 | 89.06 | 50.71 | 53.19 | 56.79 |
MD Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Pediatrix Medical Group, Inc. returns 4.4% to shareholders annually primarily through share buybacks. The earnings yield of 8.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.2% | 9.1% | — | — | 5.3% | 5.6% | — | — | 8.9% | 6.4% | 5.2% |
| FCF Yield | 12.9% | 13.9% | 16.9% | 13.6% | 11.0% | 1.9% | 8.4% | 14.5% | 8.0% | 9.2% | 6.5% |
| Buyback Yield | 4.4% | 4.8% | 0.2% | 0.1% | 7.1% | 0.2% | 0.4% | 6.2% | 10.0% | 1.4% | 1.0% |
| Total Shareholder Yield | 4.4% | 4.8% | 0.2% | 0.1% | 7.1% | 0.2% | 0.4% | 6.2% | 10.0% | 1.4% | 1.0% |
| Shares Outstanding | — | $85M | $83M | $82M | $84M | $86M | $86M | $84M | $92M | $94M | $94M |
Peer Comparison
Compare MD with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MDYou | $2B | 12.1 | 8.9 | 7.7 | 24.7% | 12.1% | 20.3% | 14.8% | 2.6 |
 THC | $16B | 11.5 | 6.0 | 6.2 | 82.3% | 16.1% | 16.1% | 13.2% | 3.1 |
 NKTR | $1B | -6.8 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 AMSF | $590M | 12.7 | 8.9 | 66.1 | 46.4% | 18.6% | 18.5% | 21.9% | 0.0 |
 HCA | $84B | 13.3 | 8.6 | 11.0 | 41.5% | 15.8% | — | 19.9% | 3.2 |
 UHS | $9B | 6.2 | 5.5 | 10.5 | 90.4% | 11.5% | 21.0% | 12.3% | 2.1 |
 CYH | $428M | 0.8 | — | 2.1 | 8.7% | -79.4% | — | -70.1% | — |
 ACHC | $2B | -2.1 | 8.4 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 |
 SEM | $2B | 14.0 | 12.1 | 5.4 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 |
 UNH | $369B | 30.7 | 18.1 | 23.0 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $129B | 72.9 | 14.3 | 16.6 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
MD — Frequently Asked Questions
Quick answers to the most common questions about buying MD stock.
What is Pediatrix Medical Group, Inc.'s P/E ratio?
Pediatrix Medical Group, Inc.'s current P/E ratio is 12.1x. The historical average is 26.3x. This places it at the 15th percentile of its historical range.
What is Pediatrix Medical Group, Inc.'s EV/EBITDA?
Pediatrix Medical Group, Inc.'s current EV/EBITDA is 8.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.0x.
What is Pediatrix Medical Group, Inc.'s ROE?
Pediatrix Medical Group, Inc.'s return on equity (ROE) is 20.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 6.5%.
Is MD stock overvalued?
Based on historical data, Pediatrix Medical Group, Inc. is trading at a P/E of 12.1x. This is at the 15th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Pediatrix Medical Group, Inc.'s profit margins?
Pediatrix Medical Group, Inc. has 24.7% gross margin and 12.1% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Pediatrix Medical Group, Inc. have?
Pediatrix Medical Group, Inc.'s Debt/EBITDA ratio is 2.6x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.